LAVA Therapeutics N.V. (LVTX)
1.740
0.00 (0.00%)
Inactive · Last trade price
on Nov 20, 2025
LAVA Therapeutics Revenue
LAVA Therapeutics had revenue of $4.99M in the twelve months ending September 30, 2025, down -32.06% year-over-year. In the year 2024, LAVA Therapeutics had annual revenue of $11.98M with 77.01% growth.
Revenue (ttm)
$4.99M
Revenue Growth
-32.06%
P/S Ratio
9.38
Revenue / Employee
$146,765
Employees
34
Market Cap
45.77M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLVTX News
- 22 days ago - LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq - GlobeNewsWire
- 25 days ago - LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline - GlobeNewsWire
- 2 months ago - LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - GlobeNewsWire
- 4 months ago - LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - LAVA Reports First Quarter 2025 Financial Results, Provides Business Update - GlobeNewsWire
- 8 months ago - LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation - GlobeNewsWire
- 9 months ago - LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 10 months ago - Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang - Benzinga